Trial Profile
Efficacy of budesonide/formoterol versus terbutaline plus salmeterol/fluticasone and a fixed maintenance dose of budesonide/formoterol plus terbutaline in patients with asthma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Salmeterol/fluticasone propionate; Terbutaline
- Indications Asthma
- Focus Therapeutic Use
- Acronyms COMPASS
- 19 Nov 2020 Results of economic analysis from three clinical trials: COMPASS, COSMOS and AHEAD presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
- 01 Jan 2018 Results of pooled post-hoc analysis from six studies (STEAM, STEP, STAY, SMILE, COMPASS and AHEAD) published in the European Respiratory Journal.
- 05 Nov 2010 New trial record.